Le Lézard
Classified in: Health, Science and technology, Covid-19 virus

Precision ADM® Announces Health Canada Approval of CANSWABtm in COVID-19 Fight


WINNIPEG, Manitoba, July 10, 2020 /PRNewswire-PRWeb/ -- Precision ADM, Inc. ("Precision ADM" or "the Company"), a global medical device company and advanced manufacturing solutions provider today announced that their CANSWABtm nasopharyngeal swabs are the first Canadian-made COVID-19 testing product to receive Health Canada approval.

The Company has engineered a new 3D-printed swab design and has trademarked the name CANSWABtm for distribution. The collection capability has been clinically tested and proven statistically equivalent to a traditional flocked swab. The Company received Health Canada approval for the CANSWABtm design on June 23, 2020. Precision ADM has secured an additional 20,000 square foot facility in order to build the needed cleanroom manufacturing areas for mass-producing nasopharyngeal swabs. With the added capabilities and facilities, the Company will be able to manufacture and ship hundreds of thousands of CANSWABtm nasopharyngeal swabs per week.

Precision ADM has received multiple CANSWABtm orders from Canadian Provincial Governments, and with a letter of intent from the Federal Government of Canada, the Company is scaling up production with the goal of producing two to four million swabs per month to meet the needs of Canadians and other countries.

"We have been manufacturing surgical products such as spine devices and joint replacements for a long time, but during this pandemic, we have taken steps to make sure we are doing all we can to support a secure domestic supply chain for our healthcare system in Canada," said Precision ADM's CEO, Martin Petrak. "Adding additional 3D printing capacity to our operations will enable us to produce essential testing equipment in North America and help our communities faster."

Precision ADM is the only additive manufacturing services company in Canada that possesses ISO 13485:2016 medical device manufacturing certification and has a facility that is FDA registered. The Company possesses a Health Canada MDEL license for manufacturing and distribution of Class I medical devices. For more information, please contact Precision ADM at [email protected].

About Precision ADM Inc.
Precision ADM® is a medical device company and global engineering and manufacturing solutions provider that uses Additive Manufacturing, also known as 3D Printing, to manufacture high value components and devices for the medical, aerospace, defense, energy, and industrial sectors.

Precision ADM® has its roots in the orthopaedic medical device industry and has created a comprehensive Advanced Digital Manufacturing® process which includes Design, Engineering, and Manufacturing. Precision ADM® possesses ISO 13485:2016, AS9100 Rev D, and ISO 9001:2015 certifications.

 

SOURCE Precision ADM


These press releases may also interest you

at 08:07
Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has released a comprehensive contract research organization (CRO) offering tailor-made for sponsors looking to bring diagnostic products...

at 08:05
Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the enrollment of the first patient in a pilot study collecting patient-generated health data (PGHD) during proton radiotherapy for lung cancer in...

at 08:05
Roivant and Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare inflammatory and autoimmune diseases, today announced the successful completion of enrollment in its Phase 2 study evaluating namilumab for...

at 08:05
Revvity, Inc. will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT in Las Vegas, NV. Senior Vice President and Chief Financial Officer Max Krakowiak will provide an update on the Company and its...

at 08:05
Freedom Biosciences, Inc. ("Freedom Bio" or the "Company"), a clinical-stage biotechnology platform focused on developing next-generation neuropsychiatric therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has notified the...

at 08:05
Microbion Corporation today announced that the company won the Advanced Wound Care Summit's Innovation Showcase award. The Innovation Showcase was designed to give presenters, who were picked by a selection committee, an opportunity to demonstrate...



News published on and distributed by: